Figure 4
Figure 4. WT1 transcript levels in patients with continuous CR versus relapse. Median log10 change from baseline in WT1 transcript levels for patients who achieved a CR and remained in continuous CR (CCR) throughout the study () versus those who relapsed (–). Time points include: enrollment (enroll), CR, pretransplantation immunotherapy day 0 and day 14, posttransplantation immunotherapy 1 (Vax 1) and 4 (Vax 4), and last study measurement (Off-Study). Boxes signify chemotherapy treatments including induction, consolidation (Consol), and ASCT. Arrows signify immunotherapy administration.

WT1 transcript levels in patients with continuous CR versus relapse. Median log10 change from baseline in WT1 transcript levels for patients who achieved a CR and remained in continuous CR (CCR) throughout the study () versus those who relapsed (–). Time points include: enrollment (enroll), CR, pretransplantation immunotherapy day 0 and day 14, posttransplantation immunotherapy 1 (Vax 1) and 4 (Vax 4), and last study measurement (Off-Study). Boxes signify chemotherapy treatments including induction, consolidation (Consol), and ASCT. Arrows signify immunotherapy administration.

Close Modal

or Create an Account

Close Modal
Close Modal